Orchard Therapeutics plc ORTX

$ 4.93 1.02%

Quarterly report 2023-Q3
added 11-13-2023

Orchard Therapeutics plc Balance Sheet 2011-2024 | ORTX

Annual Balance Sheet Orchard Therapeutics plc

	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-39 M	-16.5 M	-30.1 M	26.9 M	-336 M	-89.9 M	-3.5 M	-	-	-	-	-
Long Term Debt	23 M	32.1 M	20.2 M	24.7 M	-	-	-	-	-	-	-	-
Long Term Debt Current	6.42 M	7.34 M	8.93 M	5.89 M	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	50.9 M	44.2 M	6.8 M	134 K	17 M	-	-	-	-	-
Total Current Liabilities	60.6 M	42.8 M	51.6 M	55.9 M	47.9 M	-	-	-	-	-	-	-
Total Liabilities	121 M	112 M	103 M	100 M	54.7 M	10.9 M	20.8 M	-	-	-	-	-
Deferred Revenue	959 K	346 K	-	-	-	2.27 M	-	-	-	-	-	-
Retained Earnings	-901 M	-750 M	-606 M	-454 M	-290 M	-59.4 M	-19.7 M	-	-	-	-	-
Total Assets	219 M	322 M	281 M	399 M	366 M	97.3 M	4.28 M	-	-	-	-	-
Cash and Cash Equivalents	68.4 M	55.9 M	55.1 M	19.1 M	336 M	-	-	-	-	-	-	-
Book Value	98.3 M	210 M	178 M	299 M	311 M	86.4 M	-16.5 M	-	-	-	-	-
Total Shareholders Equity	98.3 M	210 M	178 M	299 M	311 M	86.4 M	-16.5 M	-	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet Orchard Therapeutics plc

	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	16.2 M	18.4 M	20.7 M	23 M	25.3 M	-	29.8 M	32.1 M	32.8 M	32.7 M	18.2 M	20.2 M	20.2 M	20.2 M	20.2 M	24.7 M	24.7 M	24.7 M	24.7 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	122 M	123 M	115 M	121 M	110 M	-	116 M	112 M	114 M	100 M	93.5 M	103 M	103 M	103 M	103 M	100 M	100 M	100 M	100 M	54.7 M	-	-	-	10.9 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	742 K	752 K	634 K	959 K	1.38 M	-	889 K	346 K	1.39 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-966 M	-931 M	-918 M	-901 M	-893 M	-	-795 M	-750 M	-714 M	-677 M	-641 M	-606 M	-606 M	-606 M	-606 M	-454 M	-454 M	-454 M	-454 M	-290 M	-	-	-	-59.7 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	202 M	232 M	217 M	219 M	234 M	-	292 M	322 M	356 M	365 M	389 M	281 M	281 M	281 M	281 M	399 M	399 M	399 M	399 M	366 M	-	-	-	97.3 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	23.5 M	38.3 M	61.5 M	68.4 M	80.8 M	-	60.8 M	55.9 M	74.3 M	99.9 M	78.9 M	55.1 M	55.1 M	55.1 M	55.1 M	19.1 M	19.1 M	19.1 M	19.1 M	336 M	-	-	-	89.9 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	80.3 M	109 M	102 M	98.3 M	124 M	-	176 M	210 M	241 M	264 M	296 M	178 M	178 M	178 M	178 M	299 M	299 M	299 M	299 M	311 M	-	-	-	86.4 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	80.3 M	109 M	102 M	98.3 M	124 M	146 M	176 M	210 M	241 M	264 M	296 M	178 M	178 M	178 M	178 M	299 M	299 M	299 M	299 M	311 M	131 M	14.7 M	77.9 M	86.4 M	-	-	-	-16.5 M	-	-	-	-572 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency